Thursday, July 24th, 2008
Eli Lilly Set To Start Trials On Alzheimer's Inhibitor
Last updated on Monday, March 31, 2008
Advertisement
(INDIANAPOLIS) - Indianapolis-based Eli Lilly has announced Phase III testing of an inhibitor designed to treat Alzheimer’s disease.
The company says 1,500 patients in the US and 21 other countries will be studied for nearly two years.
Researchers are trying to find out if the inhibitor can slow the progression associated with Alzheimer's by blocking an enzyme that can crate a protein which is believed to eventually kill off brain cells estimates show that 6 to 8% of people over age 65 are affected by Alzheimer's disease, totaling approximately 5 million people in the United States alone.
When you see news happening, tell us!
Call 812.275.7555 | E-mail tips@wbiw.com | Or send an IM via your AOL, MSN or Yahoo Messenger to wbiwnews
Call 812.275.7555 | E-mail tips@wbiw.com | Or send an IM via your AOL, MSN or Yahoo Messenger to wbiwnews
Tune-in
State News Air-Schedule
| TIME | DURING |
| 6:43am | The Morning Update |
| 7:43am | The Morning Update |
| 10:30am | The Dave Ramsey Show |
| 11:30am | The Dave Ramsey Show |
| 12:30pm | The Rush Limbaugh Show |
| 1:30pm | The Rush Limbaugh Show |
| 3:30pm | The Dr. Laura Program |
| 4:30pm | The Dr. Laura Program |
